N. Zealand-Developed Cancer Drug Rights Bought By Centella Of U.S.
This article was originally published in PharmAsia News
Executive Summary
New Zealand scientists developed a cancer drug to attack selective cancer cells of tumors, a treatment bought by U.S.-based Centella Therapeutics